1. Home
  2. LEGN vs INGR Comparison

LEGN vs INGR Comparison

Compare LEGN & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • INGR
  • Stock Information
  • Founded
  • LEGN 2014
  • INGR 1906
  • Country
  • LEGN United States
  • INGR United States
  • Employees
  • LEGN N/A
  • INGR N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • INGR Packaged Foods
  • Sector
  • LEGN Health Care
  • INGR Consumer Staples
  • Exchange
  • LEGN Nasdaq
  • INGR Nasdaq
  • Market Cap
  • LEGN 7.0B
  • INGR 8.4B
  • IPO Year
  • LEGN 2020
  • INGR 1997
  • Fundamental
  • Price
  • LEGN $27.69
  • INGR $138.89
  • Analyst Decision
  • LEGN Strong Buy
  • INGR Hold
  • Analyst Count
  • LEGN 13
  • INGR 5
  • Target Price
  • LEGN $75.67
  • INGR $150.20
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • INGR 445.3K
  • Earning Date
  • LEGN 05-13-2025
  • INGR 05-06-2025
  • Dividend Yield
  • LEGN N/A
  • INGR 2.31%
  • EPS Growth
  • LEGN N/A
  • INGR N/A
  • EPS
  • LEGN N/A
  • INGR 9.47
  • Revenue
  • LEGN $728,303,000.00
  • INGR $7,361,000,000.00
  • Revenue This Year
  • LEGN $65.96
  • INGR $3.18
  • Revenue Next Year
  • LEGN $52.55
  • INGR $2.60
  • P/E Ratio
  • LEGN N/A
  • INGR $14.29
  • Revenue Growth
  • LEGN 112.46
  • INGR N/A
  • 52 Week Low
  • LEGN $29.27
  • INGR $111.54
  • 52 Week High
  • LEGN $60.87
  • INGR $155.44
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 29.04
  • INGR 61.72
  • Support Level
  • LEGN $30.25
  • INGR $134.38
  • Resistance Level
  • LEGN $33.30
  • INGR $138.74
  • Average True Range (ATR)
  • LEGN 1.78
  • INGR 2.72
  • MACD
  • LEGN -0.53
  • INGR 0.51
  • Stochastic Oscillator
  • LEGN 3.10
  • INGR 80.47

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.

Share on Social Networks: